[Federal Register Volume 81, Number 38 (Friday, February 26, 2016)]
[Notices]
[Pages 9869-9870]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04105]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request: The National
Physician Survey of Precision Medicine in Cancer Treatment (NCI)
Summary: Under the provisions of Section 3507(a)(1)(D) of the
Paperwork Reduction Act of 1995, the National Cancer Institute, the
National Institutes of Health, has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below. This proposed information
collection was previously published in the Federal Register on November
18, 2015 (80 FR 72077), and allowed 60-days for public comment. No
public comments were received. The purpose of this notice is to allow
an additional 30 days for public comment. The National Cancer Institute
(NCI), National Institutes of Health, may not conduct or sponsor, and
the respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, [email protected] or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
For Further Information Contact: To obtain a copy of the data
collection plans and instruments, or request more information on the
proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project
Officer, Division of Cancer Control and Population Sciences, 9609
Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call
non-toll-free number 240-276-6806 or Email your request, including your
address to: [email protected]. Formal requests for additional plans
and instruments must be requested in writing.
Proposed Collection: The National Physician Survey of Precision
Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of this study
is to investigate the current practice of precision medicine in cancer
treatment among medical oncologists in the U.S. This is a nationally
representative survey designed to assess oncologists' current and
potential use of genomic testing, to inform the development of
interventions to facilitate optimal use of genomic testing and to
improve patient-physician discussions of the risks, possible benefits,
and uncertainties surrounding the use of these tests. Current knowledge
of this topic is limited as there are no nationally-representative
studies on this topic to date. There are only two non-federal studies
two that have examined physicians' knowledge and attitudes regarding
somatic genetic and genomic testing. The survey will be administered by
mail and web to medical oncology physicians across the U.S. Non-
respondents will be invited to complete a follow-back survey to share
their reasons for not participating. The study findings will inform NCI
of relevant issues and concerns relating to the application of
precision medicine to current and future cancer treatment patterns and
practice. This information will also inform the development of new
funding initiatives to optimize the use of precision medicine in cancer
treatment. Additionally, information collected as part of this survey
will be used to develop physician educational materials to address
barriers to precision medicine in cancer care delivery.
OMB approval is requested for 2 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 350.
Total Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Type of Number of Number of burden per Total annual
Form name respondent respondents responses per response (in burden hour
respondent hours)
----------------------------------------------------------------------------------------------------------------
Telephone Screener............ Receptionists... 775 1 3/60 39
Precision Medicine Survey-- Oncology 175 1 20/60 58
Pilot Study. Physicians.
Precision Medicine Survey-- Oncology 600 1 20/60 200
Full Study. Physicians.
Non-response Follow-back Oncology 40 1 5/60 3
Survey. Physicians.
[[Page 9870]]
Telephone Reminder Script..... Receptionists... 600 1 5/60 50
---------------------------------------------------------------
Total..................... ................ 1,375 2,190 .............. 350
----------------------------------------------------------------------------------------------------------------
Dated: February 11, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer Institute, NIH.
[FR Doc. 2016-04105 Filed 2-25-16; 8:45 am]
BILLING CODE 4140-01-P